Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page
- Check3 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check10 days agoChange DetectedThe 403 error page’s footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check17 days agoChange DetectedThe page no longer shows the 403 Forbidden message or its Home button, leaving the main content area blank beneath the navigation.SummaryDifference0.5%

- Check24 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the study record with an error screen. As a result, the essential trial information is no longer visible.SummaryDifference16%

- Check31 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous v3.6.6. This indicates a new version of the page metadata rather than a change to the study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision indicator now reads v3.6.6, replacing v3.6.5, which represents a small internal update to the page template or content without changing the study details.SummaryDifference0.1%

Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.